OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OncoTherapy Science Inc (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3493
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.

OncoTherapy Science Inc (4564) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Licensing Agreements 15
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
Equity Offering 16
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc – Key Competitors 17
OncoTherapy Science Inc – Key Employees 18
OncoTherapy Science Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Product News 20
Aug 08, 2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc, Key Competitors 17
OncoTherapy Science Inc, Key Employees 18
OncoTherapy Science Inc, Subsidiaries 19
OncoTherapy Science Inc, Joint Venture 19

List of Figures
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ServicePower Technologies plcの企業概要及び財務/SWOT分析
    ServicePower Technologies plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and q …
  • Asiasoft Corporation Plc (AS):企業の財務及び戦略的SWOT分析
    Summary Asiasoft Corporation Plc (Asiasoft) is a technology company that offers online entertainment services. The company provides online and offline game services. It develops online games and offers online advertising services. Its MMORPG offers Atlantica online, TwelveSky 2, Ghost online, Dekaro …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • American Superconductor Corp (AMSC):企業の財務・戦略的SWOT分析
    American Superconductor Corp (AMSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BioDot Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioDot Inc (BioDot) is a non-contact and quantitative fluid dispensing system manufacturer. The company’s application comprises rapid test, cytogenetics and life science. It provides lateral flow, immunoblots, dry chemistry, low volume PCR, bio chips, biosensors, fish, karyotyping and LIS in …
  • Asseco Business Solutions S.A. (ABS):企業概要、財務及び戦略的SWOT分析
    Summary Asseco Business Solutions SA (Asseco Business) is an information technology solution provider. The company designs and develops information technology solutions for business. Its products include asseco softlab ERP, asseco softlab WMS, asseco softlab HR, asseco softlab POS, asseco Koma HR, m …
  • Sygnis AG (LIO1)-医療機器分野:企業M&A・提携分析
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products inc …
  • Allied Irish Banks, p.l.c.:企業の戦略・SWOT・財務分析
    SummaryAllied Irish Banks, p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • American Financial Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Financial Group, Inc. …
  • Peters Surgical:企業のM&A・提携動向(医療機器分野)
    Summary Peters Surgical (Peters), a subsidiary of Eurazeo SA is a medical device company that designs, manufactures and markets surgical products. The company’s products include catheters, sutures, surgical glue, cardiac ring, and accessories for surgical procedures. It provides dressings and solven …
  • The Governor and Company of the Bank of Ireland:企業の戦略・SWOT・財務分析
    SummaryThe Governor and Company of the Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ …
  • Fletcher Building Ltd:企業の戦略・SWOT・財務情報
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Amscan Holdings, Inc.:企業の戦略・SWOT・財務情報
    Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Colabor Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Colabor Group, Inc. Mergers and …
  • Vishay Intertechnology, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vishay Intertechnology, Inc. Me …
  • 7-Eleven, Inc.: Retail:企業概要およびSWOT分析
    Summary Canadean's "7-Eleven, Inc.: Retail - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, mergers …
  • Ted Baker PLC:企業の戦略・SWOT・財務分析
    Ted Baker PLC - Strategy, SWOT and Corporate Finance Report Summary Ted Baker PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tata Power Delhi Distribution Limited:企業のM&A・提携動向(エネルギー分野)
    Summary Tata Power Delhi Distribution Limited (TPDDL), formerly North Delhi Power Limited is an electricity distribution company that distributes electricity in its licensed area of North and North-West Delhi. The company serves approximately 1.35 million customers spread over in an area of 510 sq. …
  • Primark Stores Ltd:企業の戦略・SWOT・財務情報
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆